About Tenaya Therapeutics, Inc. 
Tenaya Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 33 Schemes (23.76%)
Foreign Institutions
Held by 35 Foreign Institutions (2.81%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-23 Million
Pharmaceuticals & Biotechnology
USD 228 Million ()
NA (Loss Making)
NA
0.00%
-0.69
-99.79%
2.29






